Julien Lombardi
Julien Lombardi is currently Co-Founder and Chief Technology Officer at Homeostasis. He previously worked as a Research Scientist at Chemitope Glycopeptide, Whole Animal Butcher at Hudson and Charles, and Research Assistant at The City College of New York.
Seattle Startup Homeostasis Converts Carbon Emissions into Graphite for Batteries, Backed by Saudi Aramco Investment
Seattle-area startup Homeostasis is developing technology to convert captured carbon dioxide into graphite for batteries, aiming to compete with China's dominant supply amid shifting U.S. policies and global trade tensions. The company secured strategic funding from Saudi Aramco's investment arm to scale operations and support Saudi Arabia's domestic EV supply chain ambitions.
Homeostasis, Tacoma carbon-conversion startup, wins major investment from Saudi Arabia–based company to scale CO2-to-graphite production
Tacoma-based startup Homeostasis, co-founded by Makoto Eyre and Julien Lombardi, secured a major investment from a Saudi Arabia–based company to scale converting CO2 into battery-grade synthetic graphite for lithium-ion batteries, addressing U.S. supply chain gaps.
Homeostasis raises $1.2M after $600K Pre-Seed plus Washington Department of Commerce match to fund reactor development
Homeostasis, an advanced materials startup in Tacoma, WA, raised $600,000 in Pre-Seed funding plus matching funds from the Washington Department of Commerce, bringing total reported funding to $1.2M; investors include the Shakopee Mdewakanton Sioux Community, Kayak Ventures and angel investors to support reactor development.
Seattle Startup Homeostasis Raises $1.3M to Convert Atmospheric CO₂ into Graphite for Industrial Use
Seattle-area startup Homeostasis raised $600,000 in pre-seed funding and $700,000 from Washington's Climate Commitment Act to develop technology that captures atmospheric CO₂ and converts it into graphite, a critical mineral used in batteries and defense. The company plans pilot deployments by 2026, aiming to provide carbon removal systems to industrial customers and eventually operate its own carbon-removal production facilities.
Organizations
See all 4-
Homeostasis Co-Founder, Chief Technology Officer 2022–present, Co-founder, Science Team Lead · current
-
Chemitope Glycopeptide Research Scientist 2021–2022 · past
-
Hudson and Charles Whole Animal Butcher 2020–2021 · past
Education
-
International Culinary Center 2019–2020
-
The Graduate Center, City University of New York Doctor of Philosophy - PhD, Chemistry · 2013–2019
-
Syracuse University Bachelor of Science - BS, Chemistry · 2009–2013
